1.Osteochondrogenesis with Autologous Peripheral Blood Stem Cells for Osteochondral Lesions of the Talus: Report of Five Cases
Saw KY ; Jee CSY ; Ramlan A ; Dawam A ; Saw YC ; Low SF
Malaysian Orthopaedic Journal 2022;16(No.3):128-131
Osteochondral lesions of the talus (OLTs) may progress to
ankle arthritis needing ankle arthroplasty or arthrodesis. We
report five cases of OLTs treated along the principles
developed for chondrogenesis of the knee joint with
autologous peripheral blood stem cells (PBSCs), resulting in
repair and regeneration of the bone and cartilage
components. Improvement in Ankle Osteoarthritis Scale
(AOS) scores with minimum two years follow-up showed
statistical significance (p < 0.05).
2.Autologous Peripheral Blood Stem Cell Therapy for Chronic Achilles Tendinopathy: Report of Three Cases
Saw KY ; Low SF ; Ramlan A ; Dawam A ; Saw YC ; Jee CSY
Malaysian Orthopaedic Journal 2022;16(No.2):150-154
The treatment of chronic Achilles tendinopathy (CAT)
remains challenging. We report three cases of CAT treated
with autologous peripheral blood stem cells (PBSCs),
following principles developed for chondrogenesis of the
knee joint. Outcome measurement with a minimum of one
and a half years follow-up showed significant improvement
of Victorian Institute of Sport Assessment-Achilles
questionnaire (VISA-A) scores, with reduction of tendon
thickness and inflammation on MRI scan.